Form 4: Core Labs CFO Hill Reports Performance Share Grant

Core Laboratories Inc.'s SVP & CFO, Christopher Scott Hill, reported the grant of 70,008 performance shares and a correction regarding 59 401(k) plan shares.

Summary

• SVP & CFO Christopher Scott Hill received a grant of 70,008 performance shares.
• The performance shares vest over a three-year period from January 1, 2026, to December 31, 2028.
• Vesting is contingent on Core Laboratories Inc.'s Return on Invested Capital (ROIC) performance relative to its Bloomberg Peer Group (BPG).
• Vesting percentages range from 50% (35th percentile ROIC) to 175% (85th percentile ROIC or above).
• A reduction in shares vesting above 100% will occur if absolute total shareholder return is negative during the performance period.
• The filing also corrected an inadvertent omission of 59 common shares held in the Issuer's 401(k) plan from a prior Form 4.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it aligns executive incentives with long-term shareholder value through performance-based equity, a standard and generally well-regarded practice.

Positives

• The grant of performance shares aligns management incentives with long-term shareholder value creation through ROIC targets.
• The potential for 175% vesting incentivizes exceptional performance.

Negatives

• The reduction of shares vesting above 100% if absolute total shareholder return is negative introduces a downside risk for the executive's maximum payout.

Future Outlook

The vesting of performance shares for SVP & CFO Christopher Scott Hill is tied to Core Laboratories Inc.'s Return on Invested Capital (ROIC) performance relative to its Bloomberg Peer Group over a three-year period ending December 31, 2028. The potential payout ranges from 50% to 175% of the awarded shares, with a clawback mechanism if absolute total shareholder return is negative.

Industry Context

StockSavvy.ai notes that tying executive compensation to performance metrics like ROIC and TSR is a common practice in the energy services industry, aiming to align management incentives with long-term shareholder value creation. The use of a peer group benchmark for ROIC ensures that performance is evaluated in a competitive context.

Comparison to Industry Standards

• Tying executive compensation to ROIC and TSR performance against a Bloomberg Peer Group is a standard practice in the oilfield services sector, similar to compensation structures seen at companies like Schlumberger, Halliburton, and Baker Hughes, which often incorporate relative performance metrics to incentivize competitive returns.

Stakeholder Impact

• Shareholders: Potential positive impact through incentivized management performance tied to ROIC and TSR, aligning executive interests with shareholder returns.
• Employees: No direct impact on general employees, but the compensation structure for senior management sets a precedent for performance-based incentives.

Next Steps

• Core Laboratories Inc.'s Compensation Committee will measure and determine ROIC and TSR performance at the end of the performance period (December 31, 2028).
• The performance shares will vest, if at all, on December 31, 2028, based on the determined performance.

Key Dates

Recommendation

This Form 4 filing reports a routine executive equity grant with performance-based vesting, which is a standard corporate governance practice. It does not contain information that would significantly alter the fundamental investment thesis for Core Laboratories Inc., thus a 'hold' recommendation is appropriate as it maintains the current outlook without new catalysts for 'buy' or 'sell'.

Keywords

Core Laboratories, CLB, Christopher Scott Hill, SVP & CFO, Performance Shares, Equity Grant, Insider Transaction, SEC Form 4, Executive Compensation, ROIC, Total Shareholder Return, 401k